Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Megraud

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Terapevticheskii Arkhiv|May 11, 2023
[Effectiveness of empirical <i>Helicobacter pylori</i> eradication therapy with furazolidone in Russia: results from the European Registry on <i>Helicobacter pylori</i> Management (Hp-EuReg)]D S Bordin, I N Voynovan, A S Sarsenbaeva, et al.
Terapevticheskii Arkhiv|February 1, 2019
European Registry on the management of Helicobacter pylori infection (Hp-EuReg): analysis of 2360 patients receiving first-line therapy in RussiaD S Bordin, Yu V Embutnieks, L G Vologzhanina, et al.
Terapevticheskii Arkhiv|June 30, 2020
[European registry Helicobacter pylori (Hp-EuReg): how has clinical practice changed in Russia from 2013 to 2018 years]D S Bordin, Y V Embutnieks, L G Vologzhanina, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2011
Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC projectC A González, F Megraud, A Buissonniere, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Terapevticheskii Arkhiv|May 11, 2023
[Effectiveness of empirical <i>Helicobacter pylori</i> eradication therapy with furazolidone in Russia: results from the European Registry on <i>Helicobacter pylori</i> Management (Hp-EuReg)]D S Bordin, I N Voynovan, A S Sarsenbaeva, et al.
Terapevticheskii Arkhiv|February 1, 2019
European Registry on the management of Helicobacter pylori infection (Hp-EuReg): analysis of 2360 patients receiving first-line therapy in RussiaD S Bordin, Yu V Embutnieks, L G Vologzhanina, et al.
Terapevticheskii Arkhiv|June 30, 2020
[European registry Helicobacter pylori (Hp-EuReg): how has clinical practice changed in Russia from 2013 to 2018 years]D S Bordin, Y V Embutnieks, L G Vologzhanina, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2011
Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC projectC A González, F Megraud, A Buissonniere, et al.
Pageof 7